دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries
Vincenzo Russotto, MD1,2; Sheila Nainan Myatra, MD3; John G. Laffey, MD, MA4,5; Elena Tassistro, MS1,6; Laura Antolini, PhD1,6; Philippe Bauer, MD, PhD7; Jean Baptiste Lascarrou, MD, PhD8; Konstanty Szu?drzy?ski, MD, PhD9; Luigi Camporota, MD10; Paolo Pelosi, MD11; Massimiliano Sorbello, MD12; Andy Higgs, MD13; Robert Greif, MD14,15; Christian Putensen, MD16; Christina Agvald-?hman, MD, PhD17; Athanasios Chalkias, MD, PhD18; Kristaps Bokums, MD19; David Brewster, MD20,21; Emanuela Rossi, MS1,6; Roberto Fumagalli, MD1,22; Antonio Pesenti, MD23; Giuseppe Foti, MD1,2; Giacomo Bellani, MD, PhD1,2; for the INTUBE Study Investigators
doi : 10.1001/jama.2021.1727
JAMA. 2021;325(12):1164-1172
Importance Tracheal intubation is one of the most commonly performed and high-risk interventions in critically ill patients. Limited information is available on adverse peri-intubation events.
Ventilator Weaning and Discontinuation Practices for Critically Ill Patients
Karen E. A. Burns, MD, MSc1,2,3; Leena Rizvi, BSc2; Deborah J. Cook, MD, MSc4,5; Gerald Lebovic, PhD6; Peter Dodek, MD, MHSc7; Jes?s Villar, MD, PhD3,8,9; Arthur S. Slutsky, MD, MASc1,2,3; Andrew Jones, MD10; Farhad N. Kapadia, MD11; David J. Gattas, MB, BS, MMed12,13; Scott K. Epstein, MD14; Paolo Pelosi, MD15,16; Kallirroi Kefala, MD17; Maureen O. Meade, MD, MSc5; for the Canadian Critical Care Trials Group
doi : 10.1001/jama.2021.2384
JAMA. 2021;325(12):1173-1184
Importance Although most critically ill patients receive invasive mechanical ventilation (IMV), few studies have characterized how IMV is discontinued in practice.
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Perrine Janiaud, PhD1; Cathrine Axfors, MD, PhD2,3; Andreas M. Schmitt, MD1,4; Viktoria Gloy, PhD1; Fahim Ebrahimi, MD, MSc5; Matthias Hepprich, MD6,7; Emily R. Smith, ScD, MPH8; Noah A. Haber, ScD2; Nina Khanna, MD9; David Moher, PhD10; Steven N. Goodman, MD, PhD2,11,12; John P. A. Ioannidis, MD, DSc2,11,12,13,14,15; Lars G. Hemkens, MD, MPH1,2,15
doi : 10.1001/jama.2021.2747
JAMA. 2021;325(12):1185-1195
Importance Convalescent plasma is a proposed treatment for COVID-19.
Association Between the Proportion of Black Patients Cared for at Hospitals and Financial Penalties Under Value-Based Payment Programs
Rahul Aggarwal, MD1; J. Gmerice Hammond, MD, MPH2; Karen E. Joynt Maddox, MD, MPH2,3; Robert W. Yeh, MD, MSc1; Rishi K. Wadhera, MD, MPP1
doi : 10.1001/jama.2021.0026
JAMA. 2021;325(12):1219-1221
Association of Clinician Minority Patient Caseload With Performance in the 2019 Medicare Merit-based Incentive Payment System
Kenton J. Johnston, PhD, MPH1; David J. Meyers, PhD, MPH2; Gmerice Hammond, MD, MPH3; Karen E. Joynt Maddox, MD, MPH3,4
doi : 10.1001/jama.2021.0031
JAMA. 2021;325(12):1221-1223
Screening for Hearing Loss in Older Adults
US Preventive Services Task Force
doi : 10.1001/jama.2021.2566
JAMA. 2021;325(12):1196-1201
Importance Age-related sensorineural hearing loss is a common health problem among adults. Nearly 16% of US adults 18 years or older report difficulty hearing. The prevalence of perceived hearing loss increases with age. Hearing loss can adversely affect an individual’s quality of life and ability to function independently and has been associated with increased risk of falls, hospitalizations, social isolation, and cognitive decline.
Screening for Hearing Loss in Older Adults
Cynthia Feltner, MD, MPH1,2,3; Ina F. Wallace, PhD1,4; Christine E. Kistler, MD, MASc1,3,5; Manny Coker-Schwimmer, MPH1,3; Daniel E. Jonas, MD, MPH1,2,3
doi : 10.1001/jama.2020.24855
JAMA. 2021;325(12):1202-1215
Importance Hearing loss is common in older adults and associated with adverse health and social outcomes.
Envisioning the Veterans Affairs Health Care System of the Future
Baligh R. Yehia, MD, MPP1; Stephan D. Fihn, MD, MPH2,3
doi : 10.1001/jama.2021.0961
JAMA. 2021;325(12):1143-1144
Federally Qualified Health Centers and Related Primary Care Workforce Issues
Mary Wakefield, PhD, RN1
doi : 10.1001/jama.2021.1964
JAMA. 2021;325(12):1145-1146
Removing One Barrier to Opioid Use Disorder Treatment
Melissa B. Weimer, DO, MCR1; Sarah E. Wakeman, MD2; Richard Saitz, MD, MPH3,4
doi : 10.1001/jama.2021.0958
JAMA. 2021;325(12):1147-1148
Overcoming Barriers to Treatment of Opioid Use Disorder
Yngvild Olsen, MD, MPH1; Ruchi M. Fitzgerald, MD2; Sarah E. Wakeman, MD3
doi : 10.1001/jama.2021.1741
JAMA. 2021;325(12):1149-1150
Continued Increases in Overdose Deaths Related to Synthetic Opioids
Grant T. Baldwin, PhD, MPH1; Puja Seth, PhD1; Rita K. Noonan, PhD1
doi : 10.1001/jama.2021.1169
JAMA. 2021;325(12):1151-1152
The US Regulatory System and COVID-19 Vaccines
Joshua M. Sharfstein, MD1; Jesse L. Goodman, MD, MPH2; Luciana Borio, MD3
doi : 10.1001/jama.2021.1961
JAMA. 2021;325(12):1153-1154
I Am Not Burned Out
Sarah M. Bagley, MD, MSc1
doi : 10.1001/jama.2021.2861
JAMA. 2021;325(12):1155-1156
International Variation in Intubation and Extubation Practices and Adverse Events Among Critically Ill Patients Receiving Mechanical Ventilation
Hayley B. Gershengorn, MD1,2
doi : 10.1001/jama.2021.1178
JAMA. 2021;325(12):1157-1159
Emerging Lessons From COVID-19 for the US Clinical Research Enterprise
Derek C. Angus, MD1,2; Anthony C. Gordon, MD3,4; Howard Bauchner, MD5
doi : 10.1001/jama.2021.3284
JAMA. 2021;325(12):1159-1161
Screening for Hearing Loss in Older Adults
Bevan Yueh, MD, MPH1; Jay F. Piccirillo, MD2
doi : 10.1001/jama.2021.2020
JAMA. 2021;325(12):1162-1163
Evaluation of Hypokalemia
Morgan E. Grams, MD, PhD1; Melanie P. Hoenig, MD2; Ewout J. Hoorn, MD, PhD3
doi : 10.1001/jama.2020.17672
JAMA. 2021;325(12):1216-1217
When the Human Voice Speaks Volumes About Lung Function
Kristin Walter, MD, MS
doi : 10.1001/jama.2020.22460
JAMA. 2021;325(12):1130-1131
The Coronavirus Pandemic 1 Year On—What Went Wrong?
Lawrence O. Gostin, JD1
doi : 10.1001/jama.2021.3207
JAMA. 2021;325(12):1132-1133
Survey—Many High School Students Have Experienced Violence
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.2934
JAMA. 2021;325(12):1136
Sexual Minorities Have Greater COVID-19 Risk Factors
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.3356
JAMA. 2021;325(12):1136
With Good Adherence, Daily Aspirin May Prevent Pregnancy Loss
Anita Slomski
doi : 10.1001/jama.2021.1788
JAMA. 2021;325(12):1135
Virtual Postoperative Visits Noninferior to In-Person Visits
Anita Slomski
doi : 10.1001/jama.2021.3570
JAMA. 2021;325(12):1135
Better Hypertension Control With Digital Self-monitoring
Anita Slomski
doi : 10.1001/jama.2021.3572
JAMA. 2021;325(12):1135
Molecular Point-of-Care Test Improved Influenza Care
Anita Slomski
doi : 10.1001/jama.2021.3574
JAMA. 2021;325(12):1135
Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention
Anita Slomski
doi : 10.1001/jama.2021.3576
JAMA. 2021;325(12):1135
Another Explanation for Why Cloth Masks Reduce COVID-19 Severity
Rita Rubin, MA
doi : 10.1001/jama.2021.2955
JAMA. 2021;325(12):1134
VA Nursing Homes’ History of Infection Control Shortcomings
Rita Rubin, MA
doi : 10.1001/jama.2021.3562
JAMA. 2021;325(12):1134
HHS Expands Number of People Who Can Vaccinate Against COVID-19
Rita Rubin, MA
doi : 10.1001/jama.2021.3564
JAMA. 2021;325(12):1134
“Self-Portrait as Exit Wounds”
Ankit Mehta, MD1,2
doi : 10.1001/jama.2020.27162
JAMA. 2021;325(12):1127-1129
Screening for Hearing Loss in Older Adults
Jill Jin, MD, MPH1
doi : 10.1001/jama.2021.2513
JAMA. 2021;325(12):1234
Review of Hearing Loss in Children
Daniel Fink, MD, MBA1
doi : 10.1001/jama.2021.0387
JAMA. 2021;325(12):1223-1224
Review of Hearing Loss in Children—Reply
Judith E. C. Lieu, MD, MSPH1; Margaret Kenna, MD, MPH2; Samantha Anne, MD3
doi : 10.1001/jama.2021.0390
JAMA. 2021;325(12):1224-1225
Driving Impairment Following Vaporization of Cannabis
Luke A. Downey, PhD1; Amie C. Hayley, PhD1
doi : 10.1001/jama.2021.0451
JAMA. 2021;325(12):1225
Driving Impairment Following Vaporization of Cannabis
Ping-Tao Tseng1; Mu-Hong Chen2; Chih-Sung Liang3
doi : 10.1001/jama.2021.0448
JAMA. 2021;325(12):1225-1226
Driving Impairment Following Vaporization of Cannabis
Jasvinder A. Singh, MBBS, MPH1
doi : 10.1001/jama.2021.0445
JAMA. 2021;325(12):1226
Driving Impairment Following Vaporization of Cannabis—Reply
Johannes G. Ramaekers, PhD1; Thomas R. Arkell, PhD2; Iain S. McGregor, PhD2
doi : 10.1001/jama.2021.0454
JAMA. 2021;325(12):1226-1227
